Effect of amineptine on regional extracellular concentrations of dopamine and noradrenaline in the rat brain
- PMID: 1501122
Effect of amineptine on regional extracellular concentrations of dopamine and noradrenaline in the rat brain
Abstract
The effect of amineptine (1.25-20 mg/kg i.p.), an antidepressant inhibiting dopamine uptake, on extracellular concentrations of dopamine was studied in the rat striatum and nucleus accumbens by using the microdialysis technique and two Ca++ concentrations (1.26 and 3.4 mM) in the perfusion medium. In one experiment the effect of amineptine was studied on extracellular concentrations of dopamine and noradrenaline in the frontal cortex perfused with a medium containing 1.26 mM Ca++. Basal extracellular concentrations of dopamine in the striatum and nucleus accumbens were significantly higher at 3.4 mM Ca++. At 5 to 20 mg/kg, amineptine dose-dependently increased extracellular dopamine in the striatum and nucleus accumbens. No differences were found in the effect of amineptine in the two brain regions at the two calcium concentrations. When extracellular dopamine was expressed as a percentage of basal values, amineptine (20 mg/kg) caused greater increases in rats perfused with 1.26 mM Ca++ than in rats perfused with 3.4 mM Ca++ in both brain regions. A similar effect was found when 10 microM amineptine was infused through the dialysis fiber. The effect of 10 mg/kg i.p. of amineptine on dopamine output in the two brain regions was prevented by infusing 1 microM tetrodotoxin in the dialysis fiber. In the frontal cortex, 10 and 20 mg/kg of amineptine significantly raised dopamine and noradrenaline concentrations, whereas 5 mg/kg only increased noradrenaline output significantly. At 10 mg/kg i.p., amineptine also increased extracellular noradrenaline in the dorsal hippocampus. Amineptine had no consistent effects on the concentrations of dihydroxyphenylacetic acid and homovanillic acid in the various brain regions.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review.Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S15-9. doi: 10.1097/00004850-199707003-00003. Int Clin Psychopharmacol. 1997. PMID: 9347388 Review.
-
Pharmacology of amineptine: synthesis and updating.Clin Neuropharmacol. 1989;12 Suppl 2:S13-8. doi: 10.1097/00002826-198912002-00003. Clin Neuropharmacol. 1989. PMID: 2698268 Review.
-
Electrophysiological effects of amineptine on neurones of the rat substantia nigra pars compacta: evidence for an inhibition of the dopamine uptake system.Br J Pharmacol. 1991 Nov;104(3):700-4. doi: 10.1111/j.1476-5381.1991.tb12491.x. Br J Pharmacol. 1991. PMID: 1797329 Free PMC article.
-
Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex.Eur J Pharmacol. 1993 May 19;236(2):171-5. doi: 10.1016/0014-2999(93)90586-7. Eur J Pharmacol. 1993. PMID: 8319748
-
Effect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brain.Br J Pharmacol. 1986 May;88(1):269-75. doi: 10.1111/j.1476-5381.1986.tb09495.x. Br J Pharmacol. 1986. PMID: 3708219 Free PMC article.
Cited by
-
A new strategy for antidepressant prescription.Front Neurosci. 2010 Nov 19;4:192. doi: 10.3389/fnins.2010.00192. eCollection 2010. Front Neurosci. 2010. PMID: 21151361 Free PMC article.
-
Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.Br J Pharmacol. 2003 Aug;139(7):1281-8. doi: 10.1038/sj.bjp.0705341. Br J Pharmacol. 2003. PMID: 12890707 Free PMC article.
-
Dopamine D1-like and D2-like receptors in the dorsal striatum control different aspects of attentional performance in the five-choice serial reaction time task under a condition of increased activity of corticostriatal inputs.Neuropsychopharmacology. 2013 Apr;38(5):701-14. doi: 10.1038/npp.2012.236. Epub 2012 Nov 19. Neuropsychopharmacology. 2013. PMID: 23232445 Free PMC article.